Navigation Links
Vantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds
Date:7/6/2011

benign prostatic hypertrophy (BPH). This population forms the largest part of the nocturia market and represents the greatest unmet need. The results of this trial are expected in the second half of 2011 and will be used to support the design of pivotal clinical trials. Data from previous clinical trials, presented at the American Urological Association meeting in 2010, demonstrated a dose-dependent pharmacological effect and suggested that VA106483 has the potential to be an effective and well tolerated antidiuretic for the treatment of nocturia.

About Vantia Therapeutics:

Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large areas of unmet medical need. Its strong clinical pipeline includes VA106483 for nocturia and VA111913 for dysmenorrhoea, which directly target indications that together affect many millions of people, are poorly treated and represent billion dollar markets. Vantia's strategy is to develop its proprietary drug candidates through Phase II clinical testing and then commercialise through partnerships. The Company was founded in 2008 and is backed by specialist life science investors Novo A/S, SV Life Sciences and MVM Life Science Partners.

http://www.vantiatherapeutics.com

VA106483 - Nocturia

VA106483 is a novel small molecule drug candidate discovered by Vantia Therapeutics and is in Phase II trials to treat nocturia, a common condition that causes sufferers to wake frequently during the night in order to urinate, thus interrupting sleep. VA106483 acts directly in the collecting ducts of the kidney by binding to vasopressin V2 receptors.

Nocturia increases markedly with age and is often the presenting symptom in men with benign prostatic hypertrophy (BPH), affecting at least 70% of the more than 15 million BPH patients in the United States and Europe. Treatments for
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vantia Therapeutics Pipeline Continues to Mature
2. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
3. Vantia Therapeutics Lead Candidate VA106483 Enters Phase IIb Trial for Nocturia
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  Packaging Coordinators, Inc. ... definitive agreement to acquire Penn Pharmaceutical Services Limited (Penn ... in the United Kingdom ... Hope, Pennsylvania and Tokyo ... services, including Clinical and Commercial dosage form manufacturing, as ...
(Date:7/30/2014)... 30, 2014   Medical Equipment Solutions, Corp. ... a Department of Defense (US Army) contract valued at ... mobile MRI diagnostic machine and technical support staffing. As ... the Small Business Administration (SBA), Medical Equipment is proud ... the latest medical diagnostic equipment. The SBA 8-A certification ...
(Date:7/30/2014)... 2014 Die Apex Medical Corporation ... Bereich Atemtherapie- und Druckzonenprodukte, gibt bekannt, dass ... Deutschland anfechten werden. Dieses hat entschieden, dass ... von ResMed verletze. Apex weist darauf hin, ... verschiedene Patente von ResMed Anfechtungen wegen Nichtigkeit ...
Breaking Medicine Technology:PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3
(Date:7/30/2014)... within a large teaching hospital in Ireland has shown than ... in place to minimise the risk of entrapment. The report, ... therefore emphasises the need for careful selection of patients for ... need for monitoring and maintenance of hospital bed systems. , ... falling from bed. However, although the risk for any individual ...
(Date:7/30/2014)... 2014 4DSP’s new CES720 (Compact Embedded ... designed to provide a complete and generic processing platform ... is housed in an enclosure measuring five inches per ... a low-power x86 CPU tightly coupled to a high-performance ... – VITA 57.1). The Kintex-7 410T FPGA ...
(Date:7/30/2014)... According to the American Cancer Society, an estimated ... United States in 2014. (1) NTC , a ... and financial industry, has long been a proponent of advancing ... company has further demonstrated its commitment by participating in its ... Springs event to increase awareness and fundraising efforts to benefit ...
(Date:7/30/2014)... HealthDay Reporter TUESDAY, July 29, ... are vital to good health and a long life, but ... of fruits and vegetables each day, additional daily servings don,t ... The human body may only be able to effectively process ... its ability to absorb important nutrients from extra helpings, said ...
(Date:7/30/2014)... 2014 Sagacious Consultants, the premier full-service ... to a group of charities supporting veterans—Wounded Warrior Project, ... Grider Foundation. This donation is part of Sagacious Consultants’ ... contribute a donation every year to a charity of ... surrounding communities. , “We are thrilled to make this ...
Breaking Medicine News(10 mins):Health News:High frequency of potential entrapment gaps in hospital beds 2Health News:4DSP Introduces a Compact Platform for UAVs with Embedded Processing and Flexible IO 2Health News:4DSP Introduces a Compact Platform for UAVs with Embedded Processing and Flexible IO 3Health News:4DSP Introduces a Compact Platform for UAVs with Embedded Processing and Flexible IO 4Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 2Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 3Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 4Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:Sagacious Consultants Supports Veterans Charities With $10,000 Donation 2
... help combat an increased risk for life-threatening cardiovascular diseases, ... be well // advised to monitor their blood sugar ... to a new study. ,Researchers conducted a meta-analysis ... relationship between blood sugar levels and cardiovascular disease. Results ...
... study says that Man's best friend might be able to ... dogs can smell odors from malignant tumors in urine samples. ... trained over seven months to discriminate between urine from patients ... dog was then given samples of urine from six control ...
... study researchers say the antidepressant duloxetine, also known ... fibromyalgia in women . Duloxetine works by stopping ... of the brain’s neurotransmitters that are linked to ... that is characterized by body pain, muscle tenderness, ...
... were treated for depression responded better if they had ... ,An increasing amount of research is looking at ... specifics have not been understood. Researchers conducted a study ... the treatment of depression. ,The study included 115 ...
... new study confirms the recommendation by the American Heart ... beneficial to your heart. ,A number of studies ... the reduction of heart disease. In the current study, ... dietary fiber intake and the risk of coronary heart ...
... previously held belief that infants' brains don't divide into ... the brain's left hemisphere plays the leading role in ... ,Researchers are using functional magnetic resonance imaging, or ... speech. They say this is the first time fMRI ...
Cached Medicine News:Health News:High Fiber Diet Found To Protect The Heart 2Health News:fMRI Offers Insight Into An Infants Brain 2
... The DNA Engine instrument is ... Unprecedented thermal uniformity and ... and block-to-block. This rugged ... cycler, it's a platform for new ...
... Start up kit. Includes configured Laptop PC ... 1 MultiBlock satellite thermal Cycler (non-robotic). ... User friendly software. Store/track run data. ... lid. Outstanding uniformity. Advanced control ...
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
96 well format, Gradient features tests 12 PCR annealing temperatures in 1 run...
Medicine Products: